Aviya Clinical Research & Development is categorized under Medical Labs in Berkeley, CA and active since 2004.
Aviya Clinical Research & Development was established in 2004, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Coleman Gross at the company’s single location by writing to 222 Gravatt Drive, Berkeley, California CA 94705 or by phoning (510) 848-1520. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Aviya Clinical Research & Development |
| Contact Person: | Coleman Gross |
| Address: | 222 Gravatt Drive, Berkeley, California 94705 |
| Phone Number: | (510) 848-1520 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 621511 |
| Share This Business: |
Aviya Clinical Research & Development was started in 2004 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Coleman Gross for inquiries that concern Aviya Clinical Research & Development by calling the company number (510) 848-1520, as your correspondence is most welcome. Additionally, the physical location of the single location of Aviya Clinical Research & Development can be found at the coordinates 37.858672,-122.234693 as well as the street address 222 Gravatt Drive in Berkeley, California 94705.
For its online presence, you may visit Aviya Clinical Research & Development’s website at and engage with its social media outlets through on Twitter and on Facebook.